ArticleCancer immunology, immunotherapy : CII2023

Brachyury-targeted immunotherapy combined with gemcitabine against head and neck cancer.

Hidekiyo Yamaki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.